Piramal bets on contract manufacturing, OTC drugs
Results 1 to 3 of 3
Piramal Healthcare has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG through its newly created subsidiary - Piramal Imaging SA. The portfolio includes rights to florbetaben, which is in the final stages of its Phase III clinical trials
Last edited by optiontips.in; 04-15-2012 at 10:01 PM.
Piramal bets on contract manufacturing, OTC drugs
Piramal Healthcare gets hold of potential Alzheimer's tracer from Bayer